They were supportive throughout and supplemented this with helpful commercial insights and pragmatism.
The Penningtons Manches Cooper corporate team advises companies and their financial advisers and brokers on all aspects of equity capital market transactions. We focus predominantly on the mid-market and assist on IPOs, secondary fundraisings, takeovers and ongoing listed company issues.
Our specialists have the expertise to guide clients through this complex and demanding regulatory area and help them achieve their commercial goals.
We work with a wide selection of mid-market companies both in the UK and overseas, supporting them on equity markets transactions of all types. We are particularly active in the firm’s core sectors of life sciences, technology, fintech, real estate and retail. Our lawyers have extensive knowledge of the AIM community of professional advisers.
We can provide guidance on many of the key issues and assist in building the advisory team. We look to establish long-term and deep relationships with our clients and offer ongoing support as a company grows. Our team also advises on day-to-day issues affecting listed companies such as corporate governance and AGM related issues.
Advising skin health life science company SkinBioTherapeutics on a £4 million conditional placing and an associated open offer to raise up to £500,000, in order to expand its use of patented technology and explore further product and partnering opportunities.
Advising finnCap and Peel Hunt as brokers to Revolution Bars Group on a £15 million equity fundraising and finnCap as nominated adviser on its proposed move to AIM. The funds are aimed at helping the group emerge from the Covid-19 pandemic in a strong position.
Providing advice to Greenbrook Capital LLP on the £11.5 million sale of Greenbrook Healthcare, a primary care organisation that delivers services for NHS patients in urgent care and walk-in centres across London, to AIM-listed Totally Plc, a leading UK ‘out-of-hospital’ healthcare service provider.